Actinium Pharmaceuticals Net Profit Margin Growth & History (ATNM)
Actinium Pharmaceuticals's net profit margin was −37,652.22% for fiscal 2025.
View full Actinium Pharmaceuticals company overviewActinium Pharmaceuticals annual net profit margin history
| Fiscal year | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −37,652.22% | — |
| 2023 | 2023-12-31 | −60,269.14% | −57063.60 pp |
| 2022 | 2022-12-31 | −3,205.53% | −1039.97 pp |
| 2021 | 2021-12-31 | −2,165.56% | — |
Actinium Pharmaceuticals quarterly net profit margin
| Fiscal quarter | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 79.72% | — |
| Q3 2025 | 2025-09-30 | −5,701.11% | — |
| Q3 2022 | 2022-09-30 | −21,053.33% | −18296.68 pp |
| Q2 2022 | 2022-06-30 | −17,260.00% | −15372.41 pp |
| Q1 2022 | 2022-03-31 | −545.64% | +309.67 pp |
| Q4 2021 | 2021-12-31 | −34,826.09% | — |
| Q3 2021 | 2021-09-30 | −2,756.65% | — |
| Q2 2021 | 2021-06-30 | −1,887.59% | — |
| Q1 2021 | 2021-03-31 | −855.31% | — |
Actinium Pharmaceuticals net profit margin trends
Between the periods ended 2021-12-31 and 2025-12-31, Actinium Pharmaceuticals's net profit margin decreased from −2,165.56% to −37,652.22%, a change of −35486.66 percentage points. The latest reported quarter, Q2 2026, shows 79.72%.
What net profit margin means
Net profit margin measures the percentage of revenue remaining as net income after operating costs, interest, taxes, and other expenses. It shows how much bottom-line profit or loss a company generates from each dollar of revenue.
How net profit margin is calculated
TickerStat calculates net profit margin as SEC-reported net income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Actinium Pharmaceuticals source filings ↗